Gestational toxoplasmosis treatment changes the child’s prognosis: A cohort study in southern Brazil
PLOS Neglected Tropical Diseases · 2023
DOI: 10.1371/journal.pntd.0011544 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift PLOS Neglected Tropical Diseases, 2023. Verfasst von Ana Gabriela Gomes Ferrari Strang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Health Sciences Center, University Hospital of Maringá (HUM), State University of Maringá, Paraná (UEM), Brazil. Hauptthemen laut MEDLINE: Pregnancy Complications, Infectious, Toxoplasmosis, Toxoplasmosis, Congenital, Neutropenia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade Estadual de Maringá.
Abstract (Originalsprache)
Background
We evaluate the drug treatment for pregnant women with acute toxoplasmosis to reduce the risk of congenital infection, side effects (prenatal and postnatal treatment in children) and the hazard of discontinuing the infant’s medication.
Methods
We conducted a prospective cohort study to assess the risks of congenital toxoplasmosis among children born to acutely infected women with and without treatment. We examined the relationship between "exposed" and "infected children", "number of infant neutrophils", "prenatal" and "postnatal treatment". Factor analysis of mixed data (FAMD) was used to analyze the data. All children started treatment at the hospital.
Findings
Between 2017 and 2021, 233 pregnant women were evaluated at the University Hospital of Maringá; ninety-four met criteria for acute gestational toxoplasmosis. We followed up 61 children; eleven (18%) had the infection confirmed and 50 (82%) were free of toxoplasmosis (exposed). Children born to untreated mothers have 6.5-times higher risk of being infected; the transmission rate among untreated mothers was 50% versus 8.3% among treated ones. Three decreasing values of immunoglobulin G were a security parameter for stopping the child’s medication in the exposed group (50/61). Neutropenia was the leading side effect among children and the infected had a 2.7 times higher risk. There was no correlation between maternal use of pyrimethamine and children’s neutropenia.
Interpretation
The follow-up of women with acute T . gondii infection and their children, through a multidisciplinary team, availability of anti- T . gondii serology and pre- and post-natal treatments reduced the risk of toxoplasmosis transmission.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine, Health Sciences Center, University Hospital of Maringá (HUM), State University of Maringá, Paraná (UEM), Brazil.
- Postgraduate Program in Health Science, Health Sciences Center, State University of Maringá (UEM), Paraná, Brazil.
- Postgraduate Program in Food Science, Institute of Chemistry, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil.
- Parasitology Laboratory, Department of Basic Health Sciences, State University of Maringá (UEM), Paraná, Brazil.
ORCID-Profile: Ana Gabriela Gomes Ferrari Strang
Förderung
- Universidade Estadual de Maringá
Zitieren
APA
Gomes Ferrari Strang, A. G., Ferrar, R. G., & Falavigna-Guilherme, A. L. (2023). Gestational toxoplasmosis treatment changes the child’s prognosis: A cohort study in southern Brazil. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0011544
Vancouver
Gomes Ferrari Strang AG, Ferrar RG, Falavigna-Guilherme AL. Gestational toxoplasmosis treatment changes the child’s prognosis: A cohort study in southern Brazil. PLOS Neglected Tropical Diseases. 2023. doi:10.1371/journal.pntd.0011544
BibTeX
@article{GomesFerrariStrang2023,
author = {Gomes Ferrari Strang, Ana Gabriela and Ferrar, Rafaela Gomes and Falavigna-Guilherme, Ana Lúcia},
title = {Gestational toxoplasmosis treatment changes the child’s prognosis: A cohort study in southern Brazil},
journal = {PLOS Neglected Tropical Diseases},
year = {2023},
doi = {10.1371/journal.pntd.0011544}
}
EUVIMED